Skip to content
Open access · CC-BY via OpenAlex

TARGETING THE MTOR NETWORK TO MAXIMIZE HEALTHSPAN

Viviana Pérez

Innovation in Aging · 2019

Abstract

Abstract The mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) is a key nutrient and growth factor-responsive pathway that has emerged as a central regulator of aging. Inhibition of mTOR complex I in particular has been found to increase lifespan and improve functional declines during aging in yeast, worms, flies, and mice. Recently clinical studies have provided the first evidence that similar effects may be achievable in pet dogs and in elderly people. This session will focus on new discoveries related to mTOR signaling and aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/geroni/igz038.1349
Canonical
link ↗
Fetched
2026-10-07 MST

Cite this

APA
Pérez, V. (2019). TARGETING THE MTOR NETWORK TO MAXIMIZE HEALTHSPAN. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igz038.1349
Vancouver
Pérez V. TARGETING THE MTOR NETWORK TO MAXIMIZE HEALTHSPAN. Innovation in Aging. 2019. doi:10.1093/geroni/igz038.1349.
BibTeX
@article{viviana2019TARGET, title = {TARGETING THE MTOR NETWORK TO MAXIMIZE HEALTHSPAN}, author = {Viviana Pérez}, journal = {Innovation in Aging}, year = {2019}, doi = {10.1093/geroni/igz038.1349}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings